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ABSTRACT
Fine-tuning of X chromosomal gene expression in
Drosophila melanogaster involves the selective
interaction of the Dosage Compensation Complex
(DCC) with the male X chromosome, in order to
increase the transcription of many genes. However,
the X chromosomal DNA sequences determining
DCC binding remain elusive. By adapting a
‘one-hybrid’ assay, we identified minimal DNA
elements that direct the interaction of the key DCC
subunit, MSL2, in cells. Strikingly, several such
novel MSL2 recruitment modules have very different
DNA sequences. The assay revealed a novel, 40bp
DNA element that is necessary for recruitment of
DCC to an autosomal binding site in flies in the
context of a longer sequence and sufficient by itself
to direct recruitment if trimerized. Accordingly,
recruitment of MSL2 to the single 40bp element in
cells was weak, but as a trimer approached the
power of the strongest DCC recruitment site known
to date, the roX1 DH site. This element is the
shortest MSL2 recruitment sequence known to
date. The results support a model for MSL2
recruitment according to which several different,
degenerate sequence motifs of variable affinity
cluster and synergise to form a high affinity site.
INTRODUCTION
In Drosophila melanogaster, as in many animals,
the female state is deﬁned by the presence of two
X chromosomes, but males contain only a single
X chromosome in addition to the gene-poor Y chromo-
some. A priori, the genome of male fruit ﬂies appears
unbalanced due to the halved dosage of X chromosomal
genes. Re-establishment of proper balance requires a
compensatory mechanism that raises the expression
levels of the single male X chromosome to match the
expression from the two X chromosomes in females (1–3).
Failure of such ‘dosage compensation’ is lethal to the
aﬀected males (for reviews see (4–8)). Dosage compensa-
tion in ﬂies is achieved through a male-speciﬁc ribonu-
cleoprotein complex, the Dosage Compensation Complex
(DCC, also known as the Male Speciﬁc Lethal or MSL
complex), which is able to distinguish the X chromosome
from the autosomes and to bind the X selectively. The
DCC consists of ﬁve core proteins (MSL1, -2, -3, MOF
and MLE) and two non-coding RNAs, roX1 and roX2
(for review see (8) and references therein). Gene activation
involves modiﬁcation of X chromosomal chromatin by the
DCC-associated acetyltransferase MOF, which acetylates
histone H4at lysine 16 (9–11), but contributions from
more general factors, such as the H3 serine 10 kinase Jil1
(12,13), the supercoiling factor (14) and nuclear pore
components (15) have been suggested. The targeting of
these eﬀects to the X chromosome relies primarily on
MSL1 and MSL2, the two DCC proteins that are able
to recognize a subset of sites on the X chromosome even in
the absence of all other factors (16–18). However, faithful
occupancy of all sites on the X chromosome requires
additional factors, such as the activities of the acetyl-
transferase MOF and the RNA helicase MLE, as well as
the presence of the roX RNAs (19,20).
How the DCC recognizes a single chromosome is a
question of great interest. Ultimately, recognition must
involve X-speciﬁc DNA sequences. Combining chromatin
immunoprecipitation (ChIP) with probing of high-density
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the interaction of the DCC with the X chromosome has
recently been mapped (21,22). These studies revealed
that about 25% of the X chromosomal DNA is bound by
DCC in tissue culture cells or Drosophila embryos and,
notably, the majority of DCC binding is found within
coding sequences, reaﬃrming an earlier suggestion that
the DCC may act to facilitate transcription elongation
rather than initiation (23). However, despite this
wealth of interaction data it has not been possible to
distil a set of ‘consensus’ DNA sequences that deﬁne DCC
binding (21,22). It therefore remains possible that the
observed X chromosomal binding pattern of the DCC is
governed by more than just DNA sequence. DNA
sequence may just deﬁne a subset of ‘primary’ targeting
sites from which the DCC is distributed to secondary
sites in neighbouring chromatin. Because the DCC
interacts preferentially with active genes it is possible
that the process of transcription itself or a transcription-
associated epigenetic modiﬁcation of chromatin generates
secondary sites (21,22).
While the nature of those presumed secondary sites is
entirely unclear, the existence of primary sites, deﬁned by
DNA sequences with autonomous DCC recruitment
activity, has been inferred from P-element-mediated
insertion of X-derived sequences into autosomes, where
association of the DCC with these ectopic sites can
be monitored on polytene chromosomes by immuno-
histochemistry. The ﬁrst DCC binding sites characterized
in this way correspond to  200bp sequences found in the
coding regions of the roX1 and roX2 genes (24,25).
A prominent feature in these sequences is an abundance
of GA sequences, and mutation of GAGAG tracts
signiﬁcantly reduced the recruiting power of the roX2
element (25). Unfortunately, bioinformatic eﬀorts failed
to detect related DCC targeting sequences on the
X chromosome (25) and the third binding site character-
ized in some detail lacked GAGAG sequences altogether
(26). Primary DCC targeting elements thus diﬀer in DNA
sequence and may therefore belong to diﬀerent classes.
According to the currently accepted model, many
targeting elements of varying aﬃnity are spread across
the X chromosome. Strong targeting elements are able to
autonomously recruit the DCC to an ectopic integration
site on an autosome even at reduced concentrations of
MSL proteins. In contrast, weaker sites are only bound in
the X chromosomal context, presumably because the
density of targeting elements leads to an increased
local DCC concentration (26–30). This model was
substantiated by the analysis of 11 X-chromosomal
fragments of varying aﬃnity for DCC isolated by ChIP
(29). An attempt to identify sequence motifs responsible
for DCC recruitment from a subset of these ‘DCC Binding
Fragments’ (DBFs) with high- and moderate-aﬃnity
highlighted a number of clustered motifs (29).
Accordingly, a DCC binding site may be composed of
clusters of variable combinations of several degenerate
sequence motifs. However, perhaps due to the relatively
large size of the fragments analysed, it was not possible
to predict further DCC binding based on the clustering
of these motifs (29).
Thus, several previous studies indicate that the
DNA sequences comprising high aﬃnity DCC binding
sites are diverse, possess varying aﬃnities for the DCC,
and can be dispersed over several kb (21,22,24,26,29).
Given the degeneracy of the DNA motifs seen in
association with DCC interaction, one has to assume
that the contributions of individual elements to overall
DCC targeting may be small and hence diﬃcult to
document by established methodology. In order to
monitor the eﬀect of weak targeting determinants, we
developed a sensitive transfection-based ‘one-hybrid’
assay that ampliﬁes weak DNA interaction events into a
strong transcriptional read-out. The assay allows rapid
identiﬁcation of sequence elements able to recruit the
MSL2 protein. We applied the assay to localize the
DCC binding determinants within several previously
described high aﬃnity DBFs (29). We describe several
sequence motifs that contribute to MSL binding and show
that high aﬃnity MSL binding sites can be generated by
oligomerization of weaker elements.
MATERIALS AND METHODS
Drosophila genetics
Fly genetic manipulation and crossing was performed as
in ref. (29). A more detailed description is provided in the
Supplementary Data online.
FISH and immunostaining of polytenechromosomes
FISH and Immunostaining were performed exactly as
described in (29). For immunostaining, one of two aﬃnity
puriﬁed rabbit anti-MSL1 antibodies kindly provided by
M. Kuroda (31) and E. Schulze (32) were used at a
dilution of 1:200 and 1:400, respectively.
DNase-I hypersensitive site mapping
DNase-I hypersensitive (DH) sites in adult ﬂies were
mapped as described (24), except that nuclei from 2.5g
adult ﬂies, sorted according to sex, were divided into
seven portions and digested with a titration of up to
60units DNase-I (Roche, Penzberg, Germany). Ten mg
DNase-I-digested DNA per lane was digested with
restriction enzymes as described in ﬁgure legends, run on
0.8% agarose gels, then blotted and hybridized as
described (33).
Northern hybridization
Total RNA was recovered by grinding adult male or
female ﬂies under liquid nitrogen, then extracting
the powder with Qiazol (Qiagen, Hilden, Germany)
reagent according to manufacturer’s instructions.
Twenty mg of RNA from male and females was run
on a 1.2% agarose gel containing formaldehyde, then
transferred and hybridized according to standard labora-
tory protocols (34).
Plasmid constructs
Plasmids made for use in this publication are detailed in
Supplementary Table 2.
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SL2 cells were maintained in culture at 268C and split
every 3–4days. For transfection, cells were diluted to
2.5 10
5cells/ml at 1ml per well of a 12-well tissue culture
plate. The following day, the cells were transfected using
the Eﬀectene reagent (Qiagen) according to manufac-
turer’s instructions, with the single exception that 20ml
Eﬀectene reagent was used per mg of transfected DNA. Per
well of cells, the following amounts of plasmid were
transfected: pRL-TK, 15ng; pGL3-TK and derivatives,
315ng; pVP16 and other activator constructs, 160ng.
Each tested ﬁreﬂy reporter plasmid was transfected into
duplicate wells, and on at least two occasions using DNA
prepared from two diﬀerent maxipreps. DNA was
prepared using Qiagen or Promega maxiprep kits. Two
days following transfection, cells were harvested by
centrifugation and washed in 1ml PBS. Cells were then
lysed and luciferase activities determined using the Dual
Luciferase Kit (Promega, Mannheim, Germany) accord-
ing to manufacturer’s instructions. Light emission was
measured using a Lumat 9501 Luminometer (Berthold,
Bad Wildbad, Germany).
Western blotting
Western analysis was performed according to standard
laboratory protocols (34) using antibodies directed against
MSL1 (32), MSL2 and HSV VP16 (Santa Cruz Biotech,
SC7545, Santa Cruz, CA, USA).
RESULTS
DNase-I hypersensitive site mappingis of limited value for
DCC binding site localization
The previously isolated DBF5, DBF6, DBF7, DBF9 and
DBF12 are considered to contain high aﬃnity binding
sites for the DCC (29). However, given that these
fragments are between 2.5 and 6.7kb long, localizing the
targeting elements requires further mapping. So far, DBFs
have been characterized by integration of candidate
fragments into autosomes through P-element-mediated
gene transfer and monitoring of DCC recruiting power
by MSL1 immunostaining on polytene chromosomes.
In order to guide the construction of further clones for
this analysis we ﬁrst explored whether DNase-I hyper-
sensitivity (DH) would highlight regions of interest.
DNase-I hypersensitivity analysis indicates chromosomal
loci where chromatin is disrupted due to the interaction of
non-histone proteins (35). The three known high-aﬃnity
DCC binding sites within the roX genes and at cytological
position 18D10 (24,25,36) all contain regions of male-
speciﬁc DNase-I hypersensitivity, and in the case of
the roX genes these isolated sites are alone able to recruit
the DCC.
Adult ﬂies were sorted according to sex, nuclei prepared
and treated mildly with DNase-I to digest only the
most exposed sites in chromatin. DH sites within the
DBFs were identiﬁed by indirect end-labelling
(Supplementary Figure S1). DH sites were present in
every DBF clone, but notably, only two contained
male-speciﬁc sites. A strong and a weak general DH site
(i.e. common to both sexes) were found in DBF12 within
intronic sequences of the Smr gene. A single, weak male-
speciﬁc site was found in DBF6, spanning an intron and
coding sequences of the nej gene. The remaining DH sites
revealed in clones DBF-5, -7 and -9 (Supplementary
Figure S1) are summarized as follows: Two general sites
were found at the 50 ends of two neighbouring genes
(CG15892 and CG3815) in DBF5. In DBF7, a male-
speciﬁc site was seen in the vicinity of two small introns of
CG2025, and a general site was present between the
CG2025 and CG1847 genes. Lastly, in DBF9, three DH
sites present in both sexes were found in an intron of the
Tao-1 gene.
To examine whether DH sites found in both sexes could
direct DCC targeting, the strong (DHS-S) and weak
(DHS-W) general DH sites from DBF12 were chosen for
rigorous testing of DCC recruitment potential. P-elements
containing these sequences were generated and integrated
into autosomes of transgenic ﬂies. We determined the
insertion sites by DNA FISH on polytene chromosomes
(data not shown) and then monitored the recruitment of
DCC to these ectopic sites by staining with MSL1
antibody. The 480bp DHS-S was capable of recruiting
MSL1 in both wild type and msl-3
1 mutant ﬂies (Figure
1A and B), demonstrating that this sequence contains a
high aﬃnity DCC binding site. In contrast, a 700bp
fragment containing DHS-W failed to recruit MSL
proteins in three transgenic lines under wild type DCC
expression (data not shown).
The single, weak male-speciﬁc site found in DBF6,
spanning an intron and coding sequences of the nej gene,
was also tested for DCC recruitment in transgenic ﬂies.
A 500bp fragment containing the DH site and ﬂanking
sequences recruited MSL1 to an autosomal insertion site
in wild type males (Figure 1C), but was relatively weak
compared to the DBF12 DHS-S. No MSL1 binding could
be detected on the DBF6 DH insertion in ﬂies carrying the
msl-3
1 mutation (data not shown) or at the reduced DCC
levels obtained when MSL2 is provided only by the
expression mutant SXB-1 or NOPU in females (data not
shown) (27,29,37). Only under conditions of MSL1 and
MSL2 overexpression was robust binding to the DBF6
DH site seen (Figure 1D). A hexamer of this sequence
showed improved binding in wild type ﬂies (Figure 1E),
but was still not capable of recruiting the DCC at lower
DCC concentrations that characterize the SXB-1 and
NOPU genetic backgrounds. Therefore in this instance, a
male-speciﬁc DHS was not suﬃcient to deﬁne a high
aﬃnity binding site for the DCC, and the presence of a
male speciﬁc site is a poor indicator of DCC recruiting
ability.
A‘one-hybrid’ transfection assaytoexamine MSL2
recruitment tocandidate DNA
It had become clear that DHS mapping was of only
limited diagnostic value for the identiﬁcation of DCC
interaction sites. Also, P-element-mediated transgenesis
was considered too time consuming to attempt narrowing
down the DBFs to minimal DNA elements. We therefore
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of candidate DCC targeting sequences employing
co-transfection of three plasmids in male Drosophila SL2
cells. The assay is based on the activation of a
reporter gene after transient transfection into SL2 cells
(Figure 2A). Candidate DCC binding sites are cloned in
front of the ﬁreﬂy luciferase gene, which is driven by a
minimal thymidine kinase (tk) promoter. To convert
recruitment of a key DCC component (MSL2) into a
robust signal, an MSL2-VP16 fusion protein is expressed
from a second, co-transfected plasmid. This hybrid
protein consists of the entire MSL2 protein, to which
one of the strongest known transactivation domains,
taken from the Herpes Simplex Virus VP16 protein
C-terminus (38,39), is fused. The assay therefore does
not measure dosage compensation, but recruitment of
the MSL2 fusion protein to the promoter of the reporter
plasmid. ‘One-hybrid’ strategies of this kind have been
successfully employed in previous eﬀorts to uncouple
the DNA binding properties of a protein from its natural
function (40). If MSL2-VP16 is attracted to a target
sequence, either directly or indirectly through incorpora-
tion into a binding complex, the VP16 activator will boost
the expression of ﬁreﬂy luciferase. The resulting increase
in luciferase activity can be expressed as activation over
the light emission seen with the control activator,
which consists of a mutant version deleted for most
of MSL2, leaving the VP16 activation domain alone.
A second, obligatory normalization control for non-
speciﬁc eﬀects, such as transfection eﬃciency, involves
co-transfection of a Renilla luciferase expression vector.
We ﬁrst tested the functionality of the assay using the
entire roX1 cDNA, and the 217bp roX1 DHS, which
are known to contain high aﬃnity DCC binding sites
(see above; Figure 2B). As can be seen when comparing
the empty ﬁreﬂy vector pGL3 to those containing
the entire roX1 cDNA or the isolated DH site, the basal
level of luciferase activity (in the presence of VP16 only)
is heavily inﬂuenced by sequences inserted into the
vector. The roX1 cDNA produced a drop in luciferase
expression relative to empty vector, whilst the DHS
sequence alone caused an increase. This phenomenon
was seen with all sequences tested, but the roX1 sequences
shown represent the most extreme cases of repression
and activation observed. It most likely reﬂects the
juxtaposition of both real and cryptic transcription
factor binding sites to the promoter driving ﬁreﬂy
luciferase expression, or of nucleosome exclusion
sequences, and must be considered non-speciﬁc.
The eﬀect of recruiting MSL2-VP16 is therefore best
expressed as the fold activation in luciferase activity
in the presence of pMSL2-VP16 over that seen with
pVP16 (Figures 2B and 4). The assay yielded a repro-
ducible,  5-fold activation of transcription in the presence
of roX1 cDNA, but the roX1 DHS led to a robust 24-fold
activation. An additional MSL2 construct, fused to GFP
instead of VP16 and previously shown to be capable of
substituting the native MSL2 protein (41), showed
negligible activation over pVP16 in the assay, demonstrat-
ing the need for the artiﬁcial VP16 activator fusion to
observe MSL2 binding (Figure 2B).
The stronger activation of the roX1-DHS compared to
the entire cDNA suggested that the distance an MSL2
recruiting element lies from the promoter may inﬂuence
the level of luciferase activation. Within the roX1 cDNA,
the DHS is the primary element responsible for DCC
recruitment (24), and in the cDNA lies  2.3kb from the
promoter. The eﬀect of distance from the promoter was
examined in greater detail with subclones derived from
DBF12 (see below).
Isolation of anovel MSL2 binding element from DBF-12
Having determined that the one-hybrid assay could be
used to isolate small sequences crucial to DCC binding, we
applied it to isolate minimal MSL2 binding elements on
three clones (DBF-6, -9 and -12) and performed less
detailed analysis on DBF-5 and DBF-7. We ﬁrst applied
the one-hybrid assay to the  500bp DBF12 DHS-S.
A summary of the clones analysed to map an MSL2
recruitment site is shown in Figure 3. From the ﬁrst two
clones splitting the DHS in two (DBF12-L2 and -L4),
Figure 1. The DBF12 general DHS-S, but not the male-speciﬁc DBF6
DHS, constitutes a high aﬃnity DCC binding site. All panels show
polytene chromosomes from transgenic lines carrying an autosomal
insertion of the detailed DBF subsequences, stained with anti-MSL1
antibody (red) and Hoechst DNA staining (blue). In each case the
X chromosome and insertion site (arrow) are indicated. (A) Autosomal
insertion of DBF12 DHS-S visualized in a wild type male animal.
(B) The same DHS-S insertion in the msl-3
1 mutant background
(female of genotype w/w; msl-3
1,[ w þHsp83 MSL2]). (C) Autosomal
insertion of the DBF6 DHS (sequences 373–874 of DBF6) in a wild
type male. (D) DBF6 DHS under conditions of MSL1 and MSL2
overexpression (male carrying one copy of each of the [wþHsp83
MSL1] and [wþHsp83 MSL2] inserts, (27)). (E) Wild type male
ﬂy carrying an autosomal insertion of a tandem hexamer repeat of
the DBF6 DHS.
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the 50 half of the DHS, within DBF12-L2.
Proximity of the MSL2 recruiting element to the
tk promoter inﬂuences luciferase expression. In several
instances, cloning the DBF12 fragments in the reverse
orientation resulted in a higher luciferase activity,
suggesting the MSL2 binding site was closer to one end
of the fragment, which was indeed the case (compare
clones L13, L14 and L15). In an eﬀort to systematically
evaluate this distance eﬀect we modiﬁed L2 by inserting
varying lengths of spacer DNA from a fragment of
DBF12 shown to be devoid of targeting elements and
found that the assay would only give robust activation
when the MSL2 binding site was within 350bp of the
promoter (Supplementary Table 1). This is however a
conservative estimate, because the MSL2 binding site
within the DBF12-L2 clone itself already lies more than
100bp from the promoter (see below).
Restricting clone DBF12-L2 into ever-smaller frag-
ments led to the identiﬁcation of a 40bp MSL2 binding
element (DBF12-L15, see Figure 3A), which retained the
 4-fold activation potential of DBF12-L2. Trimerization
of L15 led to an MSL2-dependent 24-fold enhanced
luciferase activity (Figure 3A), rendering this oligomer
almost as potent as the native roX1 DHS (Figure 4).
Clearly, the interaction of MSL2-VP16 can be boosted by
clustering of interaction modules.
We used the one-hybrid assay to further deﬁne and
mutate the minimal MSL2 binding sequence within
DBF12. The sequence of DBF12-L15 contains runs of
adenines and a GAGA sequence (Figure 3B). A still
shorter 16bp element retaining these sequences
(DBF12-L22) still promoted MSL2-dependent luciferase
activation (Figure 3B). Mutating blocks of 4–5bp of this
16bp ‘core’ sequence in the context of the original 40bp
L15 fragment (clones L18, L19 and L23) caused a complete
loss of MSL2 recruitment, conﬁrming the importance of
this element for MSL2 binding. Conversely, mutation of a
5bp sequence outwith this core did not abolish activity
(clone L20). To explore whether the ‘GAGA motif’ in L22
was important we systematically mutated the last ‘GA’
dinucleotide. The adenine was shown to be dispensable
(clones L30–L32). In contrast, a transversion of the
adjacent guanine to a cytosine (L33) or a thymine (L35)
resulted in a complete loss of MSL2 recruitment, whilst a
transition to an adenine (L34) had little or no eﬀect. These
experiments therefore allow the requirements for MSL2
recruitment to be dissected at the single nucleotide level.
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Figure 2. A ‘one-hybrid’ transfection assay for isolation of DCC binding sites. (A) Summary of the transient transfection assay (inset) and
transfected plasmids (not to scale). pGL3-TK is modiﬁed by the insertion of candidate DCC binding sites (indicated by question marks) in front of a
minimal Herpes Simplex Virus tk promoter, and is transfected together with pRL-TK and either pMSL2-VP16 or pVP16 into Drosophila SL2 cells.
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Establishing general rules for MSL2 recruitment requires
the isolation of a panel of binding elements. We therefore
applied the one-hybrid approach to the DH sites of DBF6
and DBF9. The DBF6-L4 fragment, which contains the
male-speciﬁc DH site, recruited MSL2-VP16 to a similar
extent as DBF12 (Figure 5A). Sequentially removing
sequences from the 30 end of the DH site ﬁrst caused
an increase in luciferase activity, most likely due to moving
MSL2-binding sequences closer to the promoter, followed
by complete loss when the intron in the centre of the
DH site was removed (compare clones DBF6-L4, L5,
L6 and L7). A clone containing 68bp of only intronic
sequences (L8) recruited MSL2, although the fact
that clone L9 showed double this activity argued that
additional 50 nej coding sequences, incapable of attracting
MSL2 on their own, contribute to recruitment (Figure 5A).
The presence of similar contributing elements in coding
sequences 30 to the intron is also suggested by the higher
activity of clone L5 than L6. Removing 17bp from the
50 end of L8 did aﬀect its activity somewhat (L10), but
further removal of a CGAGAAA sequence (L11) almost
abolished activity. Further deletion into a GA repeat
resulted in complete loss of MSL2 recruitment (L12).
Restriction from the 30 end (L13 and L15) suggested that
the central GA repeat may form a core element, ﬂanked by
other sequences that contribute to MSL2 recruitment.
Fine mapping of DBF6 was therefore carried out on the
DBF6-L15 fragment, which consists of a GA repeat
ﬂanked by two short sequences (a 50 CGAGAAA and a
30 TATA motif, Figure 5B). Clones L18, -L19 and -L23
were constructed with dinucleotide substitutions within
the 50 CGAGAAA sequence. None of the dinucleotide
mutants caused complete loss of activation compared to
the parent clone, suggesting that, similar to the mutants of
DBF12 discussed above, mutation of individual bases (or
pairs in this case) can be tolerated within an essential
motif. Likewise, mutation of the entire 30 TAT motif
(clone L17) revealed its importance, but single base
substitutions (L20–L24) had little eﬀect. Deletions and
substitutions within the central dinucleotide repeat region
highlighted the role of uninterrupted GA repeats
(L26–L31). In order to explore whether GA repeats
alone were able to recruit MSL2 we mutated three bases
within L15 to construct a fragment consisting entirely of
GA repeats (L16). This sequence did not support any
MSL2 recruitment, conﬁrming the importance of the
CGAGAAA and/or TATA motifs ﬂanking the GA repeat
(Figure 5B). However, a trimer of the 26bp L16 GA
repeat sequence demonstrated robust, 7.8-fold MSL2
recruitment, providing a second example for the earlier
notion that weak elements, which by themselves are
unable to recruit MSL2, may gain aﬃnity by oligomeriza-
tion and clustering (see also Figure 4).
A similar approach was also applied to DBF9. Three
DH sites, named A, B and C had been identiﬁed in
intronic sequences at the 30 end of this clone
(Supplementary Figure S1C). Each of the DH sites was
analysed, but only DHS-C exhibited modest MSL2
recruitment (Figure 6A). Dividing DHS-C into clones
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0.9      0.2 
3.7      0.3 
DBF12
Smr
A
B
Fold
Name   Sequence  activation
DBF12-L15    CACATGGCGTAGAAACATCAAAACGAAAGAGATGGCCGCA  3.7 ± 0.3
DBF12-L16                              AAACATCAAAACGAAAGAGATGGCCGCA  2.8 ± 0.3
DBF12-L17    CACATGGCGTAGAAACATCAAAACGAAAGAGAT   2.8 ± 0.7
DBF12-L21                              AAACATCAAAACGAAAGAGAT   2.6 ± 0.6
DBF12-L22                                         TCAAAACGAAAGAGAT   3.3 ± 0.5
DBF12-L18    CACATGGCGTAGAAACATCAAAACGAATTTTTTGGCCGCA  0.9 ± 0.0
DBF12-L23    CACATGGCGTAGAAACATCAAAATCCCAGAGATGGCCGCA  0.8 ± 0.1
DBF12-L19    CACATGGCGTAGAAACATCCCCCCGAAAGAGATGGCCGCA  0.9 ± 0.0
DBF12-L20    CACATGGCGTAGCCCACTCAAAACGAAAGAGATGGCCGCA  2.6 ± 0.7
                     
DBF12-L30                         TCAAAACGAAAGAGCT   3.0 ± 0.6
DBF12-L31                             TCAAAACGAAAGAGGT   2.5 ± 0.3
DBF12-L32                           TCAAAACGAAAGAGTT   2.8 ± 0.1
DBF12-L33                        TCAAAACGAAAGACAT   1.0 ± 0.0
DBF12-L34                          TCAAAACGAAAGAAAT   3.3 ± 0.2
DBF12-L35                           TCAAAACGAAAGATAT   1.0 ± 0.1
±
±
±
±
±
±
±
±
±
±
±
Figure 3. Identiﬁcation of a 40bp MSL2 binding sequence within
DBF12. (A) DBF12 is illustrated with the identiﬁed DH sites shown as
grey bars above a scale in kb. Exons (boxes) and introns (lines) of the
Smr gene are indicated, with the arrow showing direction of
transcription. Subsequences containing DHS-S are magniﬁed, beneath
which the sequences cloned into the ﬁreﬂy luciferase reporter vector
pGL3 are indicated. Arrows under the heading ‘orientation’ refer to the
direction the fragment was cloned into the pGL3 vector; a forward
pointing arrow represents clones with the 30 end of the sequence closest
to the tk promoter. Activation of ﬁreﬂy activity with co-transfected
pMSL2-VP16 over ﬁreﬂy luciferase activity with pVP16 is indicated,
 standard deviation. (B) Fine mapping deletion and mutant clones
derived from DBF12-L15. Mutated bases are underlined. Sequences
shown are the reverse complement to their actual insertion in pGL3, to
allow easier comparison to GA sequences in DBF6 in Figure 5.
Activation of ﬁreﬂy activity with co-transfected pMSL2-VP16 com-
pared to ﬁreﬂy luciferase activity with pVP16 is indicated,  standard
deviation.
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partitioned with clone L10. Restriction of L10 from the
30 end resulted in a modest increase in activity (L7),
suggesting that MSL2 recruiting elements had been moved
closer to the promoter. Further eﬀorts therefore focused
on restricting the L7 clone to a minimal activation
element. Clones L11 and L12 deﬁned a 50 end for the
MSL2 recruiting sequences. Trimming sequences from the
30 end of L11 resulted in a sequential loss of MSL2
recruitment (L13–L15; see also Figure 6B). These obser-
vations suggested that the 50 end of L11 contains an
essential ‘core’ MSL2 recruiting element, followed at the
30 end by weaker elements, which are not essential but
contribute in a cumulative fashion to MSL2 recruitment.
Fine mapping of the DBF9 fragments therefore focused
on mutating bases in the 50 ‘core’ or 30 accessory elements
to conﬁrm this hypothesis (Figure 6B). Mutating two 5bp
blocks in the core of L13 abolished recruitment activity
(clones L16 and L17), whilst disrupting two CACA
elements in the 30 end resulted only in reduced activity
(clones L18 and L19). Therefore, these experiments
conﬁrmed that DBF9 contained an important element of
 25 nucleotides, ﬂanked by accessory elements that
contribute to MSL2 binding. The analysis pointed to the
CA dinucleotide as one such accessory motif.
In summary, examination of the smallest sequences
isolated capable of recruiting MSL2 in the transfection
assay revealed a striking lack of sequence similarity.
Whilst both DBF12-L15 and DBF6-L15 share the
AGAGA motif, and both these clones and DBF9-L13 are
generally A-rich, the only truly conserved motifs shared by
all three are AGA, GAG and AAA. These motifs are also
found in two further MSL2 recruitment sites we identiﬁed
in a less systematic search in two introns within the
DBF7 and DBF5 sequences (Supplementary Figure S2).
Extensive attempts to ﬁnd larger motifs conserved
between the sequences by allowing degenerate positions,
or including ﬂanking sequences that might contain motifs
missed in this analysis, failed to return signiﬁcant results.
NoneoftheDCCrecruitingregionsspanmale-specificRNAs
Both roX genes encode non-coding RNAs that span also
the DHS sequences responsible for DCC recruitment,
although in the case of roX2 very few, if any, transcripts
read through the DHS (25). At the 18D site, however, no
RNA could be detected in the region of the male-speciﬁc
DH site (26). We therefore examined all the DBF
sequences seen to recruit the DCC for transcripts in
male and female adult ﬂies by Northern blotting.
In contrast to both roX DH sites, but similar to the 18D
site, no male-speciﬁc transcripts could be detected
(Supplementary Figure S3), although we cannot exclude
that we have missed rare, large (48kb), developmentally
regulated transcripts, or micro-RNAs.
The one-hybrid assayidentifies bona fide DCC binding sites
Comparison of the results presented here to high
resolution ChIP-chip data for MSL1 (22) demonstrates
that most MSL2-recruiting sequences are found within
peaks of MSL1 binding (Supplementary Figure S4). These
peaks are embedded in broader regions of MSL1 binding
and it is currently unclear whether these interactions are
entirely deﬁned by DNA sequence or whether secondary
targeting determinants, such as histone modiﬁcation
marks, contribute to the observed proﬁle. In order to
ascertain that the one-hybrid assay indeed selects high
aﬃnity DCC binding sites, we tested whether the DBF12-
L15 fragment was able to recruit MSL1 to ectopic,
autosomal locations in transgenic ﬂies. An autosomal
insertion of the 40bp DBF12-L15 was not able to recruit
the DCC in wild type ﬂies (Figure 7A). However, deletion
of the L15 fragment from the DBF12 DHS-S clone caused
loss of DCC recruitment, even in a wild type male
background, conﬁrming the essential nature of the
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Figure 4. Example transfection with a member of each DBF, roX1 constructs and empty parent vectors pGL3 and pGL3mod. Data is the mean of
duplicate transfected wells with error bars showing standard deviation.
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recruited DCC to a similar or greater extent than the
parent DHS-S construct in wild type males (Figure 7C,
compare to Figure 1A), and also demonstrated robust
recruitment at low DCC concentration (SXB-1 back-
ground; Figure 7D). Thus, similar to the high aﬃnity site
at 18D (26), multimerizing an essential element not
suﬃcient to be classed as a high aﬃnity site on its own
created an artiﬁcial high aﬃnity DCC binding site.
Therefore, DBF12-L15 may well be the shortest DCC
targeting element identiﬁed to date.
DISCUSSION
A novel assayto mapDCC targeting elements
How the DCC of Drosophila recognizes the X chromo-
some for selective interaction is an unsolved question.
Although there is ample evidence that DNA sequences are
involved, deﬁning consensus sequence elements that may
serve as binding sites for DCC components has been
diﬃcult. The available evidence points to the existence of
diﬀerent sequence motifs, clustering in regions covering
several kb, which form the highest aﬃnity binding sites.
Such a deﬁnition necessitates testing numerous candidate
binding sites and extensive mutagenesis. So far, the
established method to evaluate X chromosomal sequences
for DCC recruitment is time consuming since it involves
generating stable ﬂy lines containing candidate sequences
integrated into an autosome. The ‘one-hybrid’ strategy we
introduced abbreviates this process dramatically. Fusing
the VP16 transactivation domain to MSL2 leads to a
robust activation of a reporter gene provided that MSL2 is
targeted to the candidate DNA upstream of a minimal
promoter. This strategy has several important features.
First, the assay solely measures chromosome binding of
MSL2 without constraints imposed by a requirement for
normal function in dosage compensation. This allows
mutating MSL2 regardless of potential consequences on
functions other than recruitment. Second, for the assay
to work it does not matter whether MSL2 binds the
chromosome directly or indirectly via an adaptor molecule
or even the entire DCC. Third, the assay appears to be
more sensitive for the identiﬁcation of minimal targeting
determinants than the polytene chromosome recruitment
assay. The DBF12-L15 fragment would have been missed
in the chromosome recruitment assay because its aﬃnity
for MSL2 is too weak if present as a monomer. The
element is nonetheless essential for DCC binding.
However, the dramatic increase in MSL2-responsiveness
upon trimerization led to uncovering its autonomous
recruitment potential in ﬂies. This enhanced sensitivity
may be due to the fact that MSL2 is overexpressed in SL2
cells and hence present in artiﬁcially high concentrations
that allow recognition of weak elements. Native high
aﬃnity sites may be composites of several weak elements
(see below) that individually are unable to attract DCC
autonomously, but which can be detected in the one-
hybrid assay. Finally, the assay may be adapted to a
high-throughput format, which should allow screening
many DNA sequences in parallel.
A
B
0 kb 0.5 1 1.5 2
DHS (male specific)
Name
Orien-
tation Activation
Fold 0 0.4 0.6
DBF6-L4 3.0  ±  0.9 
DBF6-L5 7.3  ±  0.2 
DBF6-L6 5.0  ±  0.6 
DBF6-L7 1.2  ±  0.3 
DBF6-L8 3.2  ±  0.6 
DBF6-L9 6.2  ±  1.4 
DBF6-L10 4.8  ±  0.9 
DBF6-L11 1.4  ±  0.3 
DBF6-L12
DBF6-L13 2.4  ±  0.5 
DBF6-L15 2.4  ±  0.5 
0.8  ±  0.3 
0.2 0.8
DBF6-L8
nej
DBF6
DBF6-L3ii 0.8  ±  0.2 
       Fold
Name       Sequence     activation
DBF6-L15    CGAGAAAGAGAGAGAGAGAGATATA 2.4  ± 0.5
DBF6-L18    CGAGACCGAGAGAGAGAGAGATATA 2.0  ± 0.3
DBF6-L23    CGATTAAGAGAGAGAGAGAGATATA 1.5  ± 0.3
DBF6-L19    CTTGAAAGAGAGAGAGAGAGATATA 2.1  ± 0.3
DBF6-L17    CGAGAAAGAGAGAGAGAGAGACCCA 1.3  ± 0.1
DBF6-L20    CGAGAAAGAGAGAGAGAGAGATACA 2.4  ± 0.4
DBF6-L21    CGAGAAAGAGAGAGAGAGAGATCTA 1.8  ± 0.4
DBF6-L22    CGAGAAAGAGAGAGAGAGAGACATA 2.1  ± 0.5
DBF6-L24    CGAGAAAGAGAGAGAGAGAGCTATA 2.1  ± 0.1
DBF6-L26    CGAGAAAGAGAGAGAGATATA   1.3 ± 0.1
DBF6-L29    CGAGAAAGAGAGAGAGAGATATA 1.9  ± 0.1
DBF6-L27    CGAGAAAGAGAGAGAGACCCCTATA 1.6  ± 0.1
DBF6-L30    CGAGAAAGAGAGACCCCGAGATATA 0.8  ± 0.0
DBF6-L31    CGAGAAACCCCGAGAGAGAGATATA 0.7  ± 0.0
DBF6-L28    CGAGAAAGAGAGACCGAGAGATATA 0.8  ± 0.0
DBF6-L16    CGAGAGAGAGAGAGAGAGAGAGAGA 1.2  ± 0.3
DBF6-(L16)3     (CGAGAGAGAGAGAGAGAGAGAGAGA)3     7.8 ± 0.2
Figure 5. Restriction of DBF6 with the one-hybrid assay. (A) DBF6
is schematized, as in Figure 3, with two magniﬁed sections. Activation
of ﬁreﬂy activity with co-transfected pMSL2-VP16 compared to
ﬁreﬂy luciferase activity with pVP16 is indicated,  standard deviation.
(B) Fine mapping and deletion clones derived from DBF6-L15.
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DHS   A    B       C
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DBF9-L3
0.9  ±  0.1 
DBF9-L4
0.7  ±  0.0 
DBF9-L5 2.1  ±  0.1 
DBF9-L9 1.5  ±  0.2 
DBF9-L10 2.3  ±  0.0 
0.8  ±  0.1 
0.7  ±  0.0 
DBF9-L13 3.2  ±  0.4 
2.2  ±  0.4 
DBF9-L6
1.5  ±  0.1 
1.2  ±  0.1 
DBF9-L7
2.8  ±  0.2 
2.4  ±  0.1 
DBF9-L11 5.2  ±  1.3 
DBF9-L12 0.7  ±  0.3 
67
7.5
7.0 7.1 7.2 7.4 7.3
AB C
C
DBF9
tao-1
DBF9-L14 1.4  ±  0.1 
DBF9-L15 1.0  ±  0.2 
          F o l d
activation Name  Sequence       
DBF9-L13  ACGCAAACGCGAAAAAGAACAGTATGCACATACACACACGTACACGAGCATACGCATTC 3.2  ± 0.4
DBF9-L14  ACGCAAACGCGAAAAAGAACAGTATGCACAT      1.4  ± 0.1
DBF9-L15  ACGCAAACGCGAAAAAGAACAG        1.0  ± 0.2
DBF9-L16  ACGGGGGGGCGAAAAAGAACAGTATGCACATACACACACGTACACGAGCATACGCATT 0.8  ± 0.0
DBF9-L17  ACGCAAACGCGAAAGGCGGCAGTATGCACATACACACACGTACACGAGCATACGCATT 1.0  ± 0.4
DBF9-L18  ACGCAAACGCGAAAAAGAACAGTATGGGGGGACACACACGTACACGAGCATACGCATT 1.9  ± 0.1
DBF9-L19  ACGCAAACGCGAAAAAGAACAGTATGCACATGCGCGCGCGTACACGAGCATACGCATT  1.9 ± 0.3
Figure 6. Restriction of DBF9 with the one-hybrid assay. (A) DBF9 is schematized, as in Figure 3, with two magniﬁed sections. For the illustrated
transcripts, ﬁlled boxes indicate coding sequence and empty boxes contain untranslated regions. Activation of ﬁreﬂy activity with co-transfected
pMSL2-VP16 compared to ﬁreﬂy luciferase activity with pVP16 is indicated,  standard deviation. (B) Fine mapping and deletion clones derived
from DBF9-L13.
Nucleic Acids Research, 2007, Vol. 35, No. 11 3569Notably, the DNA sequence elements identiﬁed as
targeting determinants resemble those found earlier with
the more established assay (see below (22,25,29)).
However, at this point we cannot exclude that the assay
only detects a subset of DCC binding sites with special
characteristics. For example, all the core sequences
identiﬁed to recruit MSL2 in this analysis lie in non-
coding regions of the genome, whereas the majority
of DCC binding is seen in coding regions (21,22).
According to a recent model (8), the DCC may interact
with chromosomes in two (or more) distinct binding
modes: a primary mode, determined largely by DNA
sequences, and a secondary mode employing transcrip-
tion-associated epigenetic features. A similar model has
recently been proposed for dosage compensation in C.
elegans (42). Accordingly, distribution of the DCC over
the X chromosome may involve primary recruitment to a
subset of sites (possibly including those identiﬁed in this
analysis) from which DCC is distributed to the majority of
secondary sites (8).
Identification of novel targeting determinants
The one-hybrid assay allowed the fast mapping of
minimal MSL2 targeting elements within larger DBFs
identiﬁed by conventional means. These are the smallest
known binding sites for the DCC. Deleting sequences
from the DBFs in our quest for minimal elements we
noticed the existence of ‘accessory’ elements, which by
themselves are not suﬃcient to recruit the DCC in the
transfection assay, but in the vicinity of a ‘core’ element
contribute to the overall aﬃnity. One such accessory motif
consists of short CA dinucleotide repeats. The core
elements appear purine-rich on one strand, and although
purine-pyrimidine transversion aﬀected activity of one
nucleotide position, it could not account for all observed
changes in activity, nor was the length of purine tract
required for activity consistent between the diﬀerent
clones. The results therefore suggested that despite a
general tolerance of mutation, some nucleotide positions
within the core may be more important than others.
However, the only sequence motifs shared between the
three shortest elements isolated are AGA, GAG and
AAA, and attempts to build longer, more ﬂexible motifs,
did not produce convincing results. The importance of
GA-rich sequences for DCC recruitment has already been
established for the roX loci (25), and they are also
common in the DBF clones (29). However, the removal of
the GAG motif from the shortest clones isolated from
DBF9 (clones DBF9-L13 and -L14) does not lead to
complete loss of MSL2 recruitment, conﬁrming that not
even this is an essential motif. On the other hand,
trimerization of an element that essentially only consists
of GA repeats can recruit MSL2 in our assay.
Together, these observations strengthen the earlier
hypothesis that high aﬃnity DBFs are composites of
several distinct sequence motifs with variable DCC
recruitment potential that synergise to generate a high
aﬃnity site. These motifs may be dispersed, but cluster to
form high aﬃnity DBFs. However, diversity in sequence
appears not to be a fundamental requirement since high
aﬃnity sites can also be generated from homotypic
elements by oligomerization, as shown here for two
examples and as was also previously observed for a
larger element (36). The relative tolerance towards point
mutations emphasizes that these elements are degenerate.
The binding speciﬁcity of the DCC therefore seems
surprisingly plastic, which may explain the failure of
genome-wide binding analyses to deﬁne a single con-
sensus. The observed degeneracy implies that each single
targeting determinant has a relatively low aﬃnity for
DCC, and we have to assume that the sum of many weak
interactions eﬀectively generate high-aﬃnity DBFs (43).
Ultimately, the future identiﬁcation of a greater number of
targeting elements should allow a better deﬁnition of the
motifs recognized by the DCC. Our conclusions are in
broad agreement with recent results from C. elegans,
where isolated or clustered motifs can render a high
aﬃnity DBF, but are not suﬃcient to explain all observed
DCC binding (44,42).
The nature of thebinding sites
Emulating previous studies (24–26), DH sites were found
in all of the ﬁve high aﬃnity DCC binding sites studied in
this analysis. However, we found for the ﬁrst time DH
sites common to both sexes that overlapped with DCC
recruiting elements, and only two of the ﬁve DBFs
contained a male-speciﬁc DH site. The single example of
a male-speciﬁc DH site tested in the transgenic ﬂy for
DCC recruitment was not capable of recruiting the DCC
with high aﬃnity, suggesting that male-speciﬁc DNase-I
hypersensitivity is merely a crude indicator of chromatin
Figure 7. The DBF12-L15 fragment is essential for DCC recruitment.
(A) Polytene immunoﬂuorescence with anti MSL1 antibody (red) and
DNA (blue), of an autosomal insertion of the 40bp L15 sequence in
wild type male background. Inset shows FISH staining (green) for
location of the autosomal insertion. Arrows show the position of the
P-element insertion, and the X chromosome is indicated in each case.
(B, C, and D) Labelling as in panel A, for (B) DBF12 DHSL15 in
wild type male background, (C) (L15)3 in wild type male background,
and (D) (L15)3 in female SXB-1 background ([wþSXB1–2 D]).
3570 Nucleic Acids Research, 2007, Vol. 35, No. 11accessibility and does not reﬂect the strength of the
underlying sequence to attract the DCC. This is similar to
the ﬁndings of the DBF at 18D, where a male-speciﬁc DH
site was necessary for high aﬃnity of a larger fragment,
but was alone not suﬃcient (26). Conceivably, regulatory
elements attracting the DCC in males may have co-opted
sequence elements and interacting factors that facilitate
chromatin opening, and so perform this function also in
females. Accessory elements may therefore not contribute
to deﬁning a DBF, but rather facilitate the interaction of
the MSLs with DNA in chromatin. For example, runs of
poly A/T tend not to be assembled into nucleosomes,
which could aid interaction of the DCC (45).
Furthermore, GAGAG sequences are found in many
regulatory elements, where the interacting proteins, such
as GAF, recruit nucleosome remodelling factors that
render nucleosomal DNA accessible (46,47).
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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